Idelalisib

Idelalisib (trade name Zydelig) is a phosphoinositide 3-kinase inhibitor for the treatment of certain hematological malignancies. Idelalisib has been approved by the U.S Food and Drug Administration on July 23, 2014.

Specifications

Product Name:                  Idelalisib

Synonyms:                         GS-1101; CAL-101

CAS Number:                     870281-82-6

Molecular Weight:            415.4289

Molecular Formula:          C22H18FN7O

Purity (HPLC):                     ≥99%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               CC[C@@H](c1nc2cccc(c2c(=O)n1c1ccccc1)F)Nc1ncnc2c1nc[nH]2

Idelalisib

  • $692.00
  • Ex Tax: $692.00

Available Options